Davita-Avalon Dialysis in Los Angeles, California - Dialysis Center

Davita-Avalon Dialysis is a medicare approved dialysis facility center in Los Angeles, California and it has 24 dialysis stations. It is located in Los Angeles county at 5807 S. Avalon Blvd., Los Angeles, CA, 90011. You can reach out to the office of Davita-Avalon Dialysis at (323) 233-2452. This dialysis clinic is managed and/or owned by Davita. Davita-Avalon Dialysis has the following ownership type - Profit. It was first certified by medicare in July, 2016. The medicare id for this facility is 552793 and it accepts patients under medicare ESRD program.

Name	Davita-Avalon Dialysis
Location	5807 S. Avalon Blvd., Los Angeles, California
No. of Dialysis Stations	24
Medicare ID	552793
Managed By	Davita
Ownership Type	Profit
Late Shifts	Yes

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Davita-Avalon Dialysis from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1659780120
Doing Business As	Total Renal Care Inc
Address	5807 Avalon Blvd Los Angeles, California, 90011
Phone Number	(323) 233-2452

Dialysis patients with Hemoglobin data	18
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL	28

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	60
  Adult patient months included in Kt/V greater than or equal to 1.2	399
  Percentage of adult patients getting regular hemodialysis at the center	87
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita-Avalon Dialysis with elevated calcium levels.

Patients with hypercalcemia	61
Hypercalcemia patient months	408
Patients with Serumphosphor	66
Patients with Serumphosphor less than 3.5 mg/dL	9
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	16
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	33
Patients with Serumphosphor from 5.6 to 7 mg/dL	26
Patients with Serumphosphor greater than 7 mg/dL	16

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	81
Patient months included in arterial venous fistula and catheter summaries	264
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment	80
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer	6

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) Year	January, 2016 - December, 2016
Patients in facility's Hospitalization Summary	15
Hospitalization Rate in facility	(Not Available)
Hospitalization Rate: Upper Confidence Limit
Hospitalization Rate: Lower Confidence Limit